Agilent Technologies

Laboratory Analytical Instruments and Consumables Market 2020-2024 | Rising Applications of Analytical Instruments to Boost Growth | Technavio

Tuesday, June 2, 2020 - 11:00pm

Our laboratory analytical instruments and consumables market report covers the following areas:

Key Points: 
  • Our laboratory analytical instruments and consumables market report covers the following areas:
    This study identifies the emergence of precision proteomics to develop personalized medicine and therapies as one of the prime reasons driving the laboratory analytical instruments and consumables market growth during the next few years.
  • Laboratory Analytical Instruments and Consumables Market 2020-2024: Vendor Analysis
    We provide a detailed analysis of vendors operating in the laboratory analytical instruments and consumables market, including some of the vendors such as Agilent Technologies Inc., AMETEK Inc., Bruker Corp., Danaher Corp., Hitachi High-Technologies Corp., HORIBA Ltd., PerkinElmer Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp.
  • Backed with competitive intelligence and benchmarking, our research reports on the laboratory analytical instruments and consumables market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Laboratory Analytical Instruments and Consumables Market 2020-2024: Key Highlights

Agilent Technologies Announces Pricing of $500 Million of Senior Notes

Monday, June 1, 2020 - 9:30pm

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets.
  • Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions.
  • This release contains forward-looking statements within the meaning of the federal securities laws, including with respect to the closing of our senior notes offering and the anticipated use of the net proceeds therefrom.
  • No assurance can be given that the securities offering discussed above will be consummated on the terms described or at all.

Agilent Technologies Announces Proposed Offering of Senior Notes

Monday, June 1, 2020 - 1:48pm

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets.
  • Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions.
  • This release contains forward-looking statements within the meaning of the federal securities laws, including with respect to our proposed senior notes offering and the anticipated use of the net proceeds therefrom.
  • No assurance can be given that the securities offering discussed above will be consummated on the terms described or at all.

Agilent Announces New Mass Spectrometry Products at ASMS 2020 Reboot

Monday, June 1, 2020 - 1:00pm

Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system.
  • The instruments are being introduced at ASMS 2020 Reboot , the interactive, online version of the annual conference of the American Society for Mass Spectrometry, being held June 1-12, 2020.
  • Agilent continues to strive to meet the evolving needs of our mass spec customers, and address the challenges they face daily, said Monty Benefiel, vice president, and general manager of Agilent's Mass Spectrometry Division.
  • These new products offer customers workflow solutions that maximize sample throughput and stability, as well as greater reliability than ever before.

Keysight Technologies to Present at Stifel 2020 Virtual Cross Sector Insight Conference

Monday, June 1, 2020 - 1:00pm

Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, announced today participation in the following upcoming virtual event with the financial community.

Key Points: 
  • Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, announced today participation in the following upcoming virtual event with the financial community.
  • ET
    Keysight Technologies, Inc. (NYSE: KEYS) is a leading technology company that helps enterprises, service providers, and governments accelerate innovation to connect and secure the world.
  • Customers span the worldwide communications ecosystem, aerospace and defense, automotive, energy, semiconductor and general electronics end markets.
  • Keysight generated revenues of $4.3B in fiscal year 2019.

Penumbra, Inc. to Present at the William Blair 40th Annual Growth Stock Conference

Friday, May 29, 2020 - 9:05pm

ALAMEDA, Calif., May 29, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 40th Annual Growth Stock Conferenceon Tuesday, June 9, 2020.

Key Points: 
  • ALAMEDA, Calif., May 29, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 40th Annual Growth Stock Conferenceon Tuesday, June 9, 2020.
  • A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com .
  • The webcast will be available on the company's website for at least two weeks following the event.
  • Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need.

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%

Friday, May 29, 2020 - 4:40pm

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Key Points: 
  • The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.
  • However, the high cost of veterinary imaging instruments is expected to restrain market growth to a certain extent.
  • The consumables segment dominates the veterinary point-of-care diagnostics market."
  • By technology, the clinical biochemistry segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018.

Keysight Technologies to Present at BofA Securities 2020 Virtual Global Technology Conference

Thursday, May 28, 2020 - 9:05pm

Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, announced today participation in the following upcoming virtual event with the financial community.

Key Points: 
  • Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, announced today participation in the following upcoming virtual event with the financial community.
  • Wednesday, June 3 at 10:45 a.m. PT
    Keysight Technologies, Inc. (NYSE: KEYS) is a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world.
  • Customers span the worldwide communications ecosystem, aerospace and defense, automotive, energy, semiconductor and general electronics end markets.
  • Keysight generated revenues of $4.3B in fiscal year 2019.

Sepsis Diagnostics Market by Technology, Product, Method, Test Type, Pathogen, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com

Thursday, May 28, 2020 - 9:19am

The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%.

Key Points: 
  • The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%.
  • The sepsis diagnostics industry is segmented on the technology, product, method, pathogen, test type, end user, and region.
  • Based on end-users, the sepsis diagnostics market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers.
  • The blood culture media segment accounted for the largest share of the sepsis diagnostics market, by product, in 2019.

Global Sepsis Diagnostics Market 2020-2025 - Evolution of Novel Biomarkers for Spesis Diagnosis Present Lucrative Opportunities

Wednesday, May 27, 2020 - 5:30pm

The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%.

Key Points: 
  • The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%.
  • The blood culture segment accounted for the largest share of the sepsis diagnostics industry, by end-user, in 2019.
  • Based on end-users, the sepsis diagnostics market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers.
  • The blood culture media segment accounted for the largest share of the sepsis diagnostics market, by product, in 2019.